Product Program year 2025 Source: CMS Open Payments

Imetelstat

Drug Hematology

Open in the dashboard

General payments

$381,624

719 payments

Research payments

$940,645

688 payments

Through program year 2025, $381,624 in general payments and $940,645 in research payments were reported against Imetelstat (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $381,624 719
2025 Research $940,645 688

Breakdown

Who paid General payments · program year 2025
  1. Geron Corporation $381,624 719 payments
Top recipients General payments · program year 2025
  1. Rami Komrokji Hematology · Tampa, FL $15,397 4% · 12 payments
  2. Amy Dezern Medical Oncology · Baltimore, MD $10,635 3% · 6 payments
  3. Guillermo Garcia-Manero Medical Oncology · Houston, TX $9,152 2% · 9 payments
  4. Elias Jabbour Hematology & Oncology · Houston, TX $8,817 2% · 9 payments
  5. Yasmin Abaza Hematology & Oncology · Chicago, IL $8,359 2% · 14 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Hematology & Oncology Internal Medicine $234,286 62% · 76 practitioners
  2. Medical Oncology Internal Medicine $71,413 19% · 20 practitioners
  3. Hematology Internal Medicine $48,147 13% · 10 practitioners
  4. Internal Medicine $20,623 5% · 6 practitioners
  5. Hospice and Palliative Medicine Internal Medicine $2,875 <1% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $69,348 18% · 18 recipients
  2. California $47,397 12% · 17 recipients
  3. Texas $46,849 12% · 11 recipients
  4. New York $27,476 7% · 12 recipients
  5. North Carolina $25,935 7% · 7 recipients

The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

719 general · 688 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record